MFS International Growth Fund
MFS SERIES TRUST X · Series S000002516 · 9 share classes
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2025 Q3
The funds investment objective is to seek capital appreciation.
The fund invests primarily in foreign equity securities, including emerging markets, selected through bottom-up fundamental analysis for above-average earnings growth potential. MFS may concentrate a significant portion of assets in a single industry, sector, country, or region, which concentrates risk in those areas.
| Share class | Gross | Net |
|---|---|---|
| MGRAX | 1.07% | 1.06% |
| MGRBX | 1.82% | 1.81% |
| MGRCX | 1.82% | 1.81% |
| MQGIX | 0.82% | 0.81% |
| MGRDX | 0.70% | 0.69% |
| MGRVX | 0.82% | 0.81% |
| MGRRX | 1.82% | 1.81% |
| MGRQX | 1.32% | 1.31% |
| MGRTX | 1.07% | 1.06% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 20.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 99.77% |
| Other | 0.00% |
Latest quarter
What changed since the fund's previous filing
New: Reckitt Benckiser Group PLC, QIAGEN NV, Novartis AG, ICICI Bank Ltd, CANADIAN DOLLAR, EURO CURRENCY, POUND STERLING
Exited: Reckitt Benckiser Group PLC, QIAGEN NV, Kotak Mahindra Bank Ltd, Canadian Natural Resources Ltd
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — | |
| — | — | — | — | — |
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| — | Taiwan Semiconductor Manufacturing Co Ltd | 5.81% | $1.40B | 22.2M |
| — | Schneider Electric SE | 3.99% | $958.08M | 2.9M |
| — | SAP SE | 3.39% | $814.01M | 4.0M |
| AEM | Agnico Eagle Mines LtdAEM | 3.12% | $748.87M | 3.0M |
| — | Nestle SA | 3.06% | $735.30M | 6.7M |
| — | AstraZeneca PLC | 3.02% | $724.81M | 3.5M |
| — | AIA Group Ltd | 2.71% | $651.03M | 58.7M |
| — | Roche Holding AG | 2.65% | $637.58M | 1.3M |
| FNV | Franco-Nevada CorpFNV | 2.57% | $616.79M | 2.2M |
| — | Rolls-Royce Holdings PLC | 2.30% | $552.57M | 30.7M |
Top 10 positions are 32.60% of net assets, top 25 59.83%, across 92 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free